AGBL2 and rheumatoid arthritis: The positivity of anti-CCP2 and RF was significantly associated with ILD in RA patients (cOR 3.83; 95% CI 1.74–8.43, p<0.001; and cOR 2.28; 95% CI 1.12–4.61, p = 0.02 respectively).